2022 Antibiotic Allergy Updates: Navigating Penicillin and Cephalosporin Allergies
Gaps in pharmacist knowledge about the management of penicillin and cephalosporin allergies can compromise patient care. Furthermore, many patients are unnecessarily diagnosed with allergies to these medications, leaving them treated with less effective antibiotics and improper antimicrobial coverage. This session will address best pharmacy practices for treating patients with allergies, flagging cross-reactivities, and de-labeling patients that have been inappropriately diagnosed with allergies to these antibiotics.
At the completion of this activity, the participant should be able to:
- Describe the risks associated with allergy mislabeling
- Assess the cross-reactivities between beta-lactams
- Identify appropriate administration strategies for patients with documented penicillin and cephalosporin allergies
- Define strategies to de-label inappropriate allergies
Briana O'Connell, PharmD, is a PGY1 Pharmacy Resident at Baystate Medical Center. She received her PharmD from Western New England University in 2022. Her professional interests include critical care and emergency medicine.
Course Fee: Free for MCPHS alumni, full-time staff, and for all other professionals.
Release Date: June 14, 2023
Expiration Date: June 14, 2024
ACPE UAN: 0026-0000-23-016-H01-P | Knowledge
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1.0 (0.1 CEU)
After registering or logging into mcphsce.org, you can view CE modules in our library.
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1.0 contact hours (0.1 CEUs).
To receive credit, participants must complete pre and post-assessments, view the entire presentation, and evaluate the session. Participant credit will be reported to the CPE Monitor upon conclusion. Transcripts may be printed from the CPE Monitor.
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.
Briana O'Connell, PharmD, has no relevant financial relationships with ineligible companies to disclose.
Content Reviewer, Lydia D'Agostino, PharmD, has no relevant financial relationships with ineligible companies to disclose.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
No funding from industry provided for this event. No exhibitors will be present.